申请人:NOVARTIS AG
公开号:WO2012066070A1
公开(公告)日:2012-05-24
The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided are pharmaceutical compositions containing these compounds and methods of treating a disease or condition mediated by CDK9 using these compounds and compositions.
本发明提供了一种化合物,其化学式为(I):以及药学上可接受的盐、对映体、立体异构体、转型异构体、互变异构体、二对映异构体或外消旋体。还提供了含有这些化合物的药物组合物,以及使用这些化合物和组合物治疗通过CDK9介导的疾病或症状的方法。